Moleculin Biotech, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
Moleculin Biotech, Inc. (MBRX) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of $1.00 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities · last filed 2018-11-13
- 2018-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $1.00M.
- 2018-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $1.00M.
- 2016-05-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $1.00M.
- 2016-05-02: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $1.00M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|---|---|
| 2018-09-30 | $1.00M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.00M 10-Q · filed 2018-08-10 |
| 2016-05-31 | $1.00M 10-Q · filed 2017-08-11 |
| 2016-05-02 | $1.00M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |